Seoul, South Korea

Bo Young Ahn


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2009-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Bo Young Ahn: Innovator in Immune Stimulating Compositions

Introduction

Bo Young Ahn is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of immunology through his innovative research and patented inventions. With a total of two patents to his name, Ahn's work focuses on developing immune-stimulating compositions that have potential applications in cancer treatment.

Latest Patents

Ahn's latest patents include:

1. **Immune stimulating composition comprising bacterial chromosomal DNA fragments having methylated CpG sequences and non-toxic lipopolysaccharides**. This invention relates to a composition that can be industrially applied as effective materials for treating cancers and as an adjuvant.

2. **Immune stimulating and controlling composition comprising bacterial chromosomal DNA fragments and non-toxic lipopolysaccharides**. This patent also focuses on a composition that can be used for treating cancers and as an adjuvant, showcasing Ahn's commitment to advancing cancer therapies.

Career Highlights

Bo Young Ahn is associated with Eyegene Inc., where he continues to work on innovative solutions in the field of immunology. His research has the potential to impact the treatment of various cancers, making him a key figure in his field.

Collaborations

Ahn collaborates with notable colleagues, including Yang Je Cho and Won Il Yoo, who contribute to his research endeavors. Their combined expertise enhances the development of effective immune-stimulating compositions.

Conclusion

Bo Young Ahn's contributions to immunology through his patented inventions highlight his role as an innovator in the field. His work has the potential to significantly impact cancer treatment and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…